Argus
•
Apr 15, 2026
INDV: Raising target price to $35.00
Summary
Indivior Pharmaceuticals Inc has an Investment Rating of HOLD; a target price of $35.000000; an Industry Subrating of High; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subratin
Upgrade to begin using premium research reports and get so much more.
Exclusive reports, detailed company profiles, and best-in-class trade insights to take your portfolio to the next level
UpgradeRelated Reports
Analyst Report: Fortrea Holdings Inc.
Apr 30, 2026
•
FTRE
BTSG: Raising target price to $52.00
Apr 29, 2026
•
BTSG
FTRE: Rating increased to a HOLD
Apr 29, 2026
•
FTRE
BTSG: What does Argus have to say about BTSG?
Apr 22, 2026
•
BTSG
FTRE: What does Argus have to say about FTRE?
Apr 22, 2026
•
FTRE
